Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 avr. 2016 16h00 HE | Source: ProQR Therapeutics N.V.

ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting

LEIDEN, Netherlands, April 25, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that the company will present pre-clinical data for QR-110 which is being developed...
07 avr. 2016 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR Announces Annual Meeting of Shareholders

LEIDEN, the Netherlands, April 07, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that the Annual General Meeting of Shareholders will be held on Tuesday, June 21,...
01 mars 2016 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR to Highlight a Growing Pipeline During a Research & Development Day and Present at the Barclays Global Healthcare Conference

LEIDEN, the Netherlands, March 01, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines...
17 févr. 2016 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR Announces Results for the Fourth Quarter and Full Year 2015

LEIDEN, the Netherlands, Feb. 17, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
03 févr. 2016 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR to Present at the Leerink Partners Global Healthcare Conference

LEIDEN, the Netherlands, Feb. 03, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines...
30 nov. 2015 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR Announces R&D Day and Provides Update on Innovation Portfolio

LEIDEN, Netherlands, Nov. 30, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
23 nov. 2015 06h30 HE | Source: ProQR Therapeutics N.V.

ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials

LEIDEN, The Netherlands, Nov. 23, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
01 oct. 2015 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences

LEIDEN, Netherlands, Oct. 1, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that the company will present abstracts with pre-clinical data for its cystic fibrosis...
23 sept. 2015 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable

LEIDEN, the Netherlands, Sept. 23, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
14 sept. 2015 07h00 HE | Source: ProQR Therapeutics N.V.

ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment

LEIDEN, the Netherlands, Sept. 14, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that PQ-010-002 is open for enrollment. The primary objective of PQ-010-002 is to...

Page précédente